Unified Innovative Power at the Life Science Location Mainz and Surrounding Areas
In the Rhine-Main-Neckar region, life science companies meet esteemed colleges and universities—creating a powerful synergy. The concentration of biotechnological research facilities and companies at one location facilitates the exchange of knowledge, services, and state-of-the-art technology in therapeutics and diagnostics.
A prime example of the relevance of collaboration between the life science industry and academia is the development of the COVID vaccine by BioNTech. This achievement has significantly strengthened the Rhine-Main-Neckar region, enhancing its visibility and relevance as an attractive location for investors, founders, and professionals in life science and biotechnology.
Another remarkable innovation from Mainz is by the biotech company Mainz Biomed, which developed an early detection test for colon cancer, offering a reliable alternative to the invasive procedure of colonoscopy—a screening test that improves the chances of cure for many people. Learn more about the company, which has been based in Mainz for over 15 years, and the motivation behind the development of cancer screening tests here: In Conversation with Mainz Biomed.